Management

Dr Glenn Tong FAICD

EXECUTIVE CHAIRMAN AND CHIEF EXECUTIVE OFFICER

Glenn has over 20 years of executive management and Board experience in rapid growth biotech companies where a core focus has been the management of product development in highly regulated environments including: pharmaceuticals, diagnostics and genetically modified crops and pastures.  Glenn has raised and managed over $100M in equity capital and collaborative R&D funding.  Past roles include: CEO and Managing Director of Gordagen Pharmaceuticals Pty Ltd., the Molecular Plant Breeding Cooperative Research Centre and Molecular Plant Breeding Pty Ltd., and AgGenomics Pty Ltd. (a subsidiary of Genetic Technologies Limited, ASX:GTG).

Glenn has a Bachelor of Science (Honours) and PhD (Chemistry) from the University of Melbourne and the Howard Florey Institute of Experimental Physiology and Medicine and is a Graduate and Fellow of the Australian Institute of Company Directors.

Mr Richard Estalella

EXECUTIVE DIRECTOR AND PRESIDENT AND CEO OF INVICTUS NUTRACEUTICALS, INC.

Executive Director and President and CEO of Invictus Nutraceuticals, Inc.

Richard Estalella is an executive and Board director with over 30 years of experience and a successful track record in the Sports Nutrition, Retail, and Multi-Level Marketing industries.  Richard was the Chief Operating Officer and then President of MusclePharm Corp in the US (OTCQB:MSLP) which during his tenure increased distribution to 50,000 retail outlets and 120 countries along with sales revenue growth from US$67M in 2012 to US$167M in 2015. He oversaw operations, finance and supply chain which included the development of global manufacturing capabilities. Richard has an Associates Arts (graduated with Honours) from Miami-Dade Community College and has completed the Babson College Retail Strategies Program.

TOP